His scientific interests lie mostly in Prostate cancer, Prostatectomy, Internal medicine, Surgery and Urology. His Prostate cancer research includes elements of Prostate, Radiation therapy and Gynecology. His research integrates issues of External beam radiotherapy, Brachytherapy, Nomogram and Adjuvant therapy in his study of Prostatectomy.
His study in Internal medicine is interdisciplinary in nature, drawing from both Oncology and Vitamin E. He combines subjects such as Bladder cancer, Nephrectomy and Cohort with his study of Surgery. As a member of one scientific family, Eric A. Klein mostly works in the field of Urology, focusing on Surgical margin and, on occasion, Positive Surgical Margin.
The scientist’s investigation covers issues in Prostate cancer, Internal medicine, Oncology, Prostatectomy and Urology. His work investigates the relationship between Prostate cancer and topics such as Prostate that intersect with problems in Pathology. The study incorporates disciplines such as Endocrinology and Gynecology in addition to Internal medicine.
His work deals with themes such as Prostate Cancer Prevention Trial and Metastasis, which intersect with Oncology. His Prostatectomy research focuses on Surgery and how it relates to Cystectomy. His research is interdisciplinary, bridging the disciplines of Stage and Urology.
His primary areas of study are Prostate cancer, Internal medicine, Oncology, Prostatectomy and Prostate. His Prostate cancer study introduces a deeper knowledge of Cancer. His Oncology research incorporates elements of Specific mortality, Gene, Allele, Biomarker and Localized disease.
Eric A. Klein focuses mostly in the field of Prostatectomy, narrowing it down to matters related to Hazard ratio and, in some cases, Proportional hazards model. His study in Prostate biopsy and Prostate-specific antigen is carried out as part of his Prostate studies. He has researched Biopsy in several fields, including PI-RADS and Gynecology.
His primary scientific interests are in Prostate cancer, Internal medicine, Oncology, Prostate and Prostatectomy. His Prostate cancer study is concerned with the larger field of Cancer. His Internal medicine study frequently draws connections to other fields, such as Gynecology.
His study on Oncology also encompasses disciplines like
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Scott M. Lippman;Eric A. Klein;Eric A. Klein;Phyllis J. Goodman;M. Scott Lucia.
Quality of life and satisfaction with outcome among prostate-cancer survivors.
Martin G. Sanda;Rodney L. Dunn;Jeff Michalski;Howard M. Sandler.
The New England Journal of Medicine (2008)
Vitamin E and the Risk of Prostate Cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT)
Eric A. Klein;Ian M. Thompson;Catherine M. Tangen;John J. Crowley.
A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score.
Jonathan I. Epstein;Michael J. Zelefsky;Daniel D. Sjoberg;Joel B. Nelson.
European Urology (2016)
Predicting the Outcome of Salvage Radiation Therapy for Recurrent Prostate Cancer After Radical Prostatectomy
Andrew J. Stephenson;Peter T. Scardino;Michael W. Kattan;Thomas M. Pisansky.
Journal of Clinical Oncology (2007)
Identification of a Novel Gammaretrovirus in Prostate Tumors of Patients Homozygous for R462Q RNASEL Variant
Anatoly Urisman;Ross J Molinaro;Ross J Molinaro;Nicole Fischer;Sarah J Plummer.
PLOS Pathogens (2006)
Salvage Radiotherapy for Recurrent Prostate Cancer After Radical Prostatectomy
Andrew J. Stephenson;Shahrokh F. Shariat;Michael J. Zelefsky;Michael W. Kattan.
Predicting 15-Year Prostate Cancer Specific Mortality After Radical Prostatectomy
Scott E. Eggener;Peter T. Scardino;Patrick C. Walsh;Misop Han.
The Journal of Urology (2011)
Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy
Andrew James Stephenson;Peter T. Scardino;James A. Eastham;Fernando J. Bianco.
Journal of Clinical Oncology (2005)
A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling
Eric A. Klein;Matthew R. Cooperberg;Cristina Magi-Galluzzi;Jeffry P. Simko.
European Urology (2014)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: